Satav, Ashish
Wairagkar, Niteen
Khirwadkar, Shubhada
Dani, Vibhawari
Rasaily, Reeta
Agrawal, Usha
Thakar, Yagnesh
Raje, Dhananjay
Siraj, Fouzia
Garge, Pradyot
Palaskar, Sameer
Kumbhare, Shraddha
Simões, Eric A. F.
Article History
Received: 31 July 2022
Accepted: 15 March 2023
First Online: 27 April 2023
Declarations
:
: This is to certify that the study, “A feasibility study of Minimal Invasive Tissue Sampling (MITS) in hospitals and community in tribal area of Melghat, central India,” has been approved by institutional ethics committee of MAHAN trust, Melghat on 9.6.2019. The institutional ethics committee of MAHAN trust was formed as per guidelines of Indian Council of Medical Research. The signed copy of the ethics approval is attached.The study has also been approved by ethical committee of government of Maharashtra (Institutional Ethics Committee for Research State Health Systems Resource Centre).The study has also been approved by Health Ministry Screening Committee of Government of India (Indian Counsel of Medical Research as technical expert).
: The informed consent form was signed by the parents of the dead children. It is as per the guidelines of Indian counsel of Medical Research and ethical committee of government of Maharashtra. The consent form is attached.
: Dr. Ashish Satav is president of MAHAN trust. MAHAN trust received grants from the MITS Surveillance Alliance, funded by the Bill and Melinda Gates Foundation Opportunity/Contract ID: OPP1180554″ to conduct the research. Dr. Ashish Satav has not received any money from the funders.Dr. Eric Simoes reports grants from Bill and Melinda Gates Foundation, during the conduct of the study; grants, personnel fees and non financial support from Astra Zenica Inc, grants, personnel fees and non financial fees form Merck and company, grants, personnel fees and non financial support from Regeneron Inc, grants, personnel fees and non financial support from Pfizer Inc, grants, personnel fees and non financial support and other from Abbvie Inc, personnel fees from Alere Inc, grants, personnel fees and non financial support from Roche Inc, other from GSK Inc, grants from Johnson and Johnson, grants and non financial support from Novavax Inc, outside the submitted work.